title: Exploiting alloreactivity for tumour immunotherapy.
authors.affiliation: Imperial College London, UK. h.stauss@imperial.ac.uk
authors.forename: H J
authors.initials: HJ
authors.lastname: Stauss
authors.forename: S
authors.initials: S
authors.lastname: Xue
authors.forename: R
authors.initials: R
authors.lastname: Gillmore
authors.forename: L
authors.initials: L
authors.lastname: Gao
authors.forename: G
authors.initials: G
authors.lastname: Bendle
authors.forename: A
authors.initials: A
authors.lastname: Holler
authors.forename: A-M
authors.initials: AM
authors.lastname: Downs
authors.forename: E
authors.initials: E
authors.lastname: Morris
mesh_terms: D006086:Graft vs Host Disease / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D011948:Receptors, Antigen, T-Cell